Prostate, 0270-4137

Tidskrift

Fler filtreringsmöjligheter
  1. 2020
  2. Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels

    Weiqiang Li, Mesude Bicak, Daniel D. Sjoberg, Emily Vertosick, Anders Dahlin, Olle Melander, David Ulmert, Hans Lilja & Robert J. Klein, 2020, I : Prostate.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2019
  4. Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy

    Xiaoning Wu, Helen Scott, Sigrid V. Carlsson, Daniel D. Sjoberg, Lucia Cerundolo, Hans Lilja, Remko Prevo, Guillaume Rieunier, Valentine Macaulay, Geoffrey S. Higgins, Clare L. Verrill, Alastair D. Lamb, Vincent T. Cunliffe, Chas Bountra, Freddie C. Hamdy & Richard J. Bryant, 2019 jul 1, I : Prostate. 79, 10, s. 1079-1089 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Expression of tSTAT3, pSTAT3 727 , and pSTAT3 705 in the epithelial cells of hormone-naïve prostate cancer

    Agnieszka Krzyzanowska, Nicholas Don-Doncow, Felicia Elena Marginean, Alexander Gaber, R. William Watson, Rebecka Hellsten & Anders Bjartell, 2019, I : Prostate. 79, 7, s. 784-797

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men

    Melissa J. Assel, Hans David Ulmert, R. Jeffery Karnes, Stephen A. Boorjian, David W. Hillman, Andrew J. Vickers, George G. Klee & Hans Lilja, 2019, I : Prostate.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. The STAT3 inhibitor galiellalactone inhibits the generation of MDSC-like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors

    Rebecka Hellsten, Lisa Lilljebjörn, Martin Johansson, Karin Leandersson & Anders Bjartell, 2019, I : Prostate. 79, 14, s. 1611-1621 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. 2018
  9. Role of serum response factor expression in prostate cancer biochemical recurrence

    Maria Prencipe, Aurelie Fabre, Thomas Brendan Murphy, Eszter Vargyas, Amanda O'Neill, Anders Bjartell, Kristin Austlid Tasken, Helene H Grytli, Aud Svindland, Viktor Berge, Lars M Eri, William Gallagher & R William Watson, 2018 jul, I : The Prostate. 78, 10, s. 724-730 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. 2017
  11. Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naïve Prostate Cancer

    Andreas Josefsson, Anna Linder, Despina Flondell Site, Giacomo Canesin, Anna Stiehm, Aseem Anand, Anders Bjartell, Jan-Erik Damber & Karin Welén, 2017 jun 1, I : Prostate. 77, 8, s. 849-858 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Clinical Correlates of Benefit From Radium-223 Therapy in Metastatic Castration Resistant Prostate Cancer

    Ajjai Alva, Luke Nordquist, Stephanie Daignault, Saby George, Jorge Ramos, Costantine Albany, Sudhir Isharwal, Matthew McDonald, Gregory Campbell, Pongwut Danchaivijitr, Sarah Yentz, Aseem Anand & Evan Y. Yu, 2017 apr 1, I : Prostate. 77, 5, s. 479-488 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2015
  14. Relationship Between Serum Response Factor and Androgen Receptor in Prostate Cancer

    Maria Prencipe, Amanda O'Neill, Gillian O'Hurley, Lan K. Nguyen, Aurelie Fabre, Anders Bjartell, William M. Gallagher, Colm Morrissey, Elaine W. Kay & R. William Watson, 2015, I : The Prostate. 75, 15, s. 1704-1717

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. 2014
  16. 2012
  17. Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050)

    Karin Jennbacken, Karin Welen, Anders Olsson, Bengt Axelsson, Marie Torngren, Jan-Erik Damber & Tomas Leanderson, 2012, I : The Prostate. 72, 8, s. 913-924

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Regional distribution of neuroendocrine cells in the urogenital duct system of the male rat

    Gerhard Aumueller, Andreas Doll, Gunther Wennemuth, Nishtman Dizeyi, Per-Anders Abrahamsson & Beate Wilhelm, 2012, I : The Prostate. 72, 3, s. 326-337

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. 2010
  20. Indoleamine 2,3-dioxygenase (IDO) activity influence tumor growth in the TRAMP prostate cancer model.

    Eva Källberg, Pernilla Wikström, Anders Bergh, Fredrik Ivars & Tomas Leanderson, 2010, I : The Prostate. 70, 13, s. 1461-1470

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Role of the ProteinTyrosine Phosphatase SHP-I in Interleukin-6 Regulation of Prostate Cancer Cells

    Helena Tassidis, Zoran Culig, Anette Gjörloff Wingren & Pirkko Härkönen, 2010, I : The Prostate. 70, 14, s. 1491-1500

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. 2009
  23. Association of Reported Prostate Cancer Risk Alleles With PSA Levels Among Men Without a Diagnosis of Prostate Cancer

    Fredrik Wiklund, S. Lilly Zheng, Jielin Sun, Hans-Olov Adami, Hans Lilja, Fang-Chi Hsu, Par Stattin, Jan Adolfsson, Scott D. Cramer, David Duggan, John D. Carpten, Bao-Li Chang, William B. Isaacs, Henrik Gronberg & Jianfeng Xu, 2009, I : The Prostate. 69, 4, s. 419-427

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.

    Nastaran Monsef, Maria Soller, Margareth Isaksson, Per-Anders Abrahamsson & Ioannis Panagopoulos, 2009, I : The Prostate. 69, s. 909-916

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. 2008
  26. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.

    Rebecka Hellsten, Martin H Johansson, Anna K Dahlman, Nishtman Dizeyi, Olov Sterner & Anders Bjartell, 2008, I : The Prostate. 68, 3, s. 269-280

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Hormonal regulation of beta(2)-adrenergic receptor level in prostate cancer

    Hakon Ramberg, Turid Eide, Kurt Allen Krobert, Finn Olav Levy, Nishtman Dizeyi, Anders Bjartell, Per-Anders Abrahamsson & Kristin Austlid Tasken, 2008, I : The Prostate. 68, 10, s. 1133-1142

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. 2007
  29. Androgens and prostate cancer risk: A prospective study

    Sara Wirén, Tanja Stocks, Sabina Rinaldi, Göran Hallmans, Anders Bergh, Ulf Håkan Stenman, Rudolf Kaaks & Pär Stattin, 2007 aug 1, I : Prostate. 67, 11, s. 1230-1237 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Localization of immunoreactive HIF-1alpha and HIF-2alpha in neuroendocrine cells of both benign and malignant prostate glands.

    Nastaran Monsef, Leszek Helczynski, Åke Lundwall & Sven Påhlman, 2007, I : The Prostate. 67, 11, s. 1219-1229

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. 2006
  32. Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer.

    J T Isaacs, R Pili, D Z Qian, S L Dalrymple, J B Garrison, N Kyprianou, A Bjork, A Olsson & Tomas Leanderson, 2006, I : The Prostate. 66, 16, s. 1768-1778

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland.

    Anders Bjartell, Rebecka Johansson, Thomas Björk, Virgil Gadaleanu, Åke Lundwall, Hans Lilja, Lars Kjeldsen & Lene Udby, 2006, I : The Prostate. 66, Dec 30, s. 591-603

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug

    Samuel Janssen, D Marc Rosen, Rebecca M Ricklis, Craig A Dionne, Hans Lilja, Soeren B Christensen, John T Isaacs & Samuel R Denmeade, 2006, I : The Prostate. 66, 4, s. 358-368

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. 2005
  36. Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue

    T Steuber, P Niemela, A Haese, K Pettersson, A Erbersdobler, K H F Chun, M Graefen, M W Kattan, H Huland & Hans Lilja, 2005, I : The Prostate. 63, 1, s. 13-18

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 Nästa